metadata toggle
Significant changes
Change titleChange detailChange dateDatasheetCreated by
ZelerisUpdated indication with the addition of Mycoplasma bovis and associated warnings and precautions.
For therapeutic treatment of bovine respiratory disease (BRD) due to Histophilus
somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma bovis
associated with pyrexia.
30 August 2023Zeleris® 400 mg/ml + 5 mg/ml solution for injection for cattleceva-rixon
Change titleChange detailChange dateDatasheetCreated by